Cardiovascular stent / polymer / drug eluting Siro™ InSitu Technologies

Cardiovascular stent / polymer / drug eluting Siro™ InSitu Technologies
Siro™


Sirolimus - Eluting Stent Combining security and reliability as the proven SIROLIMUS unites with our Direct-Stent® platform. This unique device features: The Siro™ drug eluting stent sets the bar for other stents to follow. It combines the U.S. patented Direct-Stent® design with the proven successful Sirolimus drug to reduce tissue ingrowth and proliferation leading to reduced restenosis. Proven successful Sirolimus drug Strength of a hybrid cell stent design Premounted as low as 0.9 mm Semi-compliant balloon material Direct-Stent® U.S. patented platform Clinically proven biostable polymer
a:3:{i:0;a:2:{s:4:"name";s:9:"Material:";s:3:"val";s:7:"polymer";}i:1;a:2:{s:4:"name";s:23:"Cardiovascular system :";s:3:"val";s:14:"cardiovascular";}i:2;a:2:{s:4:"name";s:16:"Characteristics:";s:3:"val";s:12:"drug eluting";}}
******
5810 Blackshire Path,
Inver Grove Heights
United States
× × × × × × ×


Endorsed Companies